[LABP] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[LABP] Landos Biopharma, Inc.
Announcement Date
12-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -44.05%
YoY- 62.17%
Quarter Report
LABP's Result
LABP's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -6,119 -5,860 -3,922 -6,034 -5,232 -7,896 -11,284 -33.42%
Tax 1,002 0 -557 -445 -1,352 67 18 1347.27%
NP -6,119 -5,860 -3,922 -5,589 -3,880 -7,963 -11,302 -33.49%
Tax Rate - - - - - - - -
Total Cost 6,119 5,860 3,922 5,589 3,880 7,963 11,302 -33.49%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.99 -0.94 -0.63 -0.86 -0.96 -1.98 -2.81 -50.02%
EPS Diluted -0.99 -0.94 -0.63 -0.86 -0.96 -1.98 -2.81 -50.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.